ONCOSEC MEDICAL Inc Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2017 to Q3 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
ONCOSEC MEDICAL Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2017 to Q3 2022.
- ONCOSEC MEDICAL Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending October 31, 2022 was -$343K, a 6.61% increase year-over-year.
- ONCOSEC MEDICAL Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.16M, a 102% decline from 2021.
- ONCOSEC MEDICAL Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $68.2M, a 140% increase from 2020.
- ONCOSEC MEDICAL Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $28.4M, a 4.42% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)